Thanks Science Translational Medicine for highlighting our study. Check out our latest work on how boosting and waning of immunity shapes dengue epidemic dynamics!

Using immunology to develop an epidemiological model capable of describing #dengue epidemic patterns is just *chef’s kiss*. Blown away by your work Rosie Aogo, PhD! Go take a look at her integrated approach in Science Translational Medicine, you won’t regret it 🤩 science.org/doi/10.1126/sc…

⭕Yellow fever ⭕Dengue ⭕Hepatitis C These diseases are all from the same viral family: the Flaviviruses. And they're not the only viruses in this large family capable of infecting humans. Learn more about these viral suspects ⬇️ #TheViralMostWanted endpandemics.cepi.net/the-flavivirus…

I'm sure you heard us talk about mega pools before. We use this method to assess T cell responses in small amounts of blood and independent of the HLA phenotype of the population, which makes it a valuable tool to assess antigen specific T cell immunity.

My department is hiring computational biologists! Come be my colleague.

Come work with me in peds ID at University of Wisconsin Department of Pediatrics!! We have an opening in our division for a new faculty member! jobs.wisc.edu/jobs/pediatric…

Inspired by Nobel Laureate Jennifer Doudna’s talk to the “home team” here UC Berkeley MCB and especially her advocacy and leadership to reduce costs for novel genome editing therapies. Her science to society effort resonates with me! TY Innovative Genomics Institute Doudna Lab 🧬

And the illustration is from our free resource CRISPRpedia.com!

⚠️Epidemiological alert issued by PAHO/WHO on #dengue, ahead of peak dengue circulation season in the southern hemisphere, ongoing viral circulation and re-emergence of serotypes in certain regions. paho.org/en/documents/e…

Exciting work that caught us by surprise! After so many years of prospective cohort follow up (19) we can finally statistically untangle the relationships across flavivirus epidemics by #dengue serotype! Nice work team! Eva Harris

UPDATED: our massive database of funding opportunities for EARLY-CAREER RESEARCHERS For each of the 496 (!!) listed opportunity, we provide description, link to funder, $ amount, deadline, and eligibility criteria (e.g. citizenship) Dowload here: research.jhu.edu/rdt/funding-op…

Most happy to share our review on facing the challenges of the escalating burden of #dengue. #PLOSGlobalPublicHealth: Facing the escalating burden of dengue: Challenges and perspectives dx.plos.org/10.1371/journa… Drugs for Neglected Diseases initiative Steven Lim Andre Siqueira Dr Kavita Singh @JMP_DNDi

A #vaccine designed to prevent human #cytomegalovirus (#CMV) elicited long-lasting CMV-specific responses from several types of immune cells, outperforming a previous vaccine concept in multiple measures in a #NIAID-supported laboratory study. Read more: go.nih.gov/IrYeN8M

I call out this critical child health fact: some children who get measles will die. #vaccines work to protect your child or a loved one

🚨 There are THREE DAYS left to apply to join the 2024 cohort of the #HannaGrayFellows Program! Learn more & apply by this Wednesday, Feb. 28th, at 3 p.m. ET! hhmi.news/3V0CXIm 👈